TCL Archive In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract September 19, 1975
TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006